
Similar Posts

Israel’s Ministry of Health Concealed Serious, Long-Lasting Covid-Vax Safety Hazards
Despite knowledge of the vaccine’s serious, life-altering hazards, officials of Israel’s Ministry of Health disregard the harm caused to thousands of people; they continue to urge the public to Get Vaccinated. A leaked, secretly taped video of a high level meeting confirms that a research team commissioned by the Israeli…
AHRP Ethical and Scientific Objections to FDA’s Proposed Licensure of Anthrax Vaccine
When a federal judge ruled the vaccine to be an "investigational drug and a drug being used for an unapproved purpose" on December 22, 2003, FDA hurriedly issued a Final Rule for anthrax vaccine. The agency submitted its Final Rule just eight days after a federal court injunction, having failed to do so for 19 years. In a January 7, 2004 court hearing the same judge called FDA’s actions "highly suspicious." On October 27, 2004 FDA’s arbitrary and capricious promulgation of this Final Rule resulted in a permanent injunction, remanding the license to your agency to complete according to the law. The injunction also halted what the judge called DoD’s "illegal" mandatory anthrax vaccination program.
CDC Measles Vaccination Rule Has Left Millions of Vaccinated Americans Without Protection
Lots of babies get measles in Africa and India, and it is a significant cause of death there. A great deal of work has gone into developing measles vaccines that can be given to children at younger and younger ages, especially in Africa, for this reason. But in the United…
FDA: Regulatory Protections for Children
Comments submitted by Vera Hassner Sharav, John H. Noble, Jr., Ph.D and Howard Fishman, MEd, MSW for AHRP
To: Dr. Bernard Schwetz Acting Commissioner Food and Drug Administration, Dockets Management Branch (HFA-305) Food and Drug Administration
Re: COMMENT ON: Docket #00N-0074 April 24, 2001 Interim Rule: "Additional Safeguards for Children in Clinical Investigations of FDA-Regulated Products
Excerpt: The FDA rightly chose not to permit the section 46.408 (c) waiver by IRBs of parental or guardian permission, as it leaves the specific circumstances for such a violation of parental rights to the discretion of local Institutional Review Boards (IRB). Given the stream of revelations of gross ethical and procedural violations at one after another of the nation’s premier research institutions, assumptions that “procedural safeguards are in place,” or that IRBs can be relied upon to make decisions that protect the best interests of human subjects – adults and children – has been debunked.
AHRP Position Statement on Mental Health Screening – FDA Hearing Re: Drug Advertising
AHRP Position Statement on Mental Health Screening – FDA Hearing Re: Drug Advertising Wed, 02 Nov 2005 FDA is holding public hearings (Nov 1, 2) Re: Direct-to-Consumer Promotion of Medical Products at: National Transportation Safety Board Boardroom and Conference Center 429 L’Enfant Plaza, SW., Washington, DC 2 Time: 9:00 –5:00….

Hero of the Week: Vera Sharav, The Solari Report
March 27, 2021 “The policy that lead to the murder of the elderly, those are exactly the triage policies that were formulated by bioethicists. And they were put in place just like that. And Andrew Cuomo, the Governor of New York, even stated, he knew exactly what this would do….